Avadel Pharmaceuticals PLC Sponsored ADR Forecast, price target & analysts
Avadel Pharmaceuticals PLC Sponsored ADR Target price 2025 - Analyst rating & recommendation
Avadel Pharmaceuticals PLC Sponsored ADR Classifications & Recommendation:
Avadel Pharmaceuticals PLC Sponsored ADR Price Target
| Target Price | $22.44 |
| Price | $21.48 |
| Potential |
4.47%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Avadel Pharmaceuticals PLC Sponsored ADR 2026 .
The average Avadel Pharmaceuticals PLC Sponsored ADR target price is $22.44.
This is
4.47%
register free of charge
$24.15
12.43%
register free of charge
$18.69
13.01%
register free of charge
|
|
| A rating was issued by 16 analysts: 6 Analysts recommend Avadel Pharmaceuticals PLC Sponsored ADR to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Avadel Pharmaceuticals PLC Sponsored ADR stock has an average upside potential 2026 of
4.47%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 169.12 | 279.84 |
| 504.86% | 65.47% | |
| EBITDA Margin | -23.49% | 12.36% |
| 95.17% | 152.63% | |
| Net Margin | -28.87% | 6.94% |
| 94.96% | 124.04% |
12 Analysts have issued a sales forecast Avadel Pharmaceuticals PLC Sponsored ADR 2025 . The average Avadel Pharmaceuticals PLC Sponsored ADR sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Avadel Pharmaceuticals PLC Sponsored ADR EBITDA forecast 2025. The average Avadel Pharmaceuticals PLC Sponsored ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Avadel Pharmaceuticals PLC Sponsored ADR Analysts have issued a net profit forecast 2025. The average Avadel Pharmaceuticals PLC Sponsored ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.51 | 0.20 |
| 74.50% | 139.22% | |
| P/E | 107.60 | |
| EV/Sales | 7.31 |
12 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast for earnings per share. The average Avadel Pharmaceuticals PLC Sponsored ADR EPS is
This results in the following potential growth metrics and future valuations:
Avadel Pharmaceuticals PLC Sponsored ADR...
Current Avadel Pharmaceuticals PLC Sponsored ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 07 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Oct 23 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 22 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 07 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Oct 23 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Oct 22 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 22 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
